Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Baricitinib is effective and safe for treating severe alopecia areata.

Goats with BSE or scrapie show varying symptoms, and using only clinical signs may not detect all scrapie cases.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Immigrant Latino workers in North Carolina, especially in poultry processing, often have skin diseases like fungal infections and acne.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

Minoxidil improved rat skin flap survival but was less effective than surgical methods.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Many patients on methotrexate experience significant side effects but still continue the medication.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

The new method accurately detects illegal hair-growth drugs in dietary supplements.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.